Cite

    Nona Janikashvili et al.. “Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect.” Oncoimmunology, vol. 10, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100122323775.0x00000f